Literature DB >> 11108170

A case of recurrent cholangitis after bile duct injury during laparoscopic cholecystectomy: value of scintigraphy with Tc-99m GSA and hepatobiliary scintigraphy for indication of lobectomy.

S Nishiguchi1, S Shiomi, N Sasaki, Y Iwata, H Tanaka, S Kubo, K Hirohashi, H Ochi.   

Abstract

A 39-year-old woman with acute cholecystitis and gallstones underwent laparoscopic cholecystectomy. She suffered from recurrent episodes of cholangitis due to injury of the major bile ducts during laparoscopic cholecystectomy. Hepatobiliary scintigraphy with Tc-99m Sn-N-pyridoxyl-5-methyltryptophan was performed. Although normal bile excretion was found from the left hepatic duct to the percutaneous transhepatic biliary drainage (PTBD) tube, excretion from the right hepatic lobe was prolonged. Scintigraphy with Tc-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin demonstrated atrophy of the right hepatic lobe and enlargement of the left hepatic lobe. Cholangiography via the PTBD tube revealed complete obstruction of the left hepatico-jejunal anastomosis and could not enhance the right intrahepatic bile duct. A right hepatic lobectomy was performed because of the atrophy, glissonitis and the absence of an appropriate bile duct for reconstruction. Postoperatively she was active and exhibited no evidence of recurrent cholangitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108170     DOI: 10.1007/bf02988702

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  2 in total

Review 1.  Hepatic resection for post-cholecystectomy bile duct injuries: a literature review.

Authors:  Stéphanie Truant; Emmanuel Boleslawski; Gilles Lebuffe; Géraldine Sergent; François-René Pruvot
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

2.  Liver resection and transplantation in the management of iatrogenic biliary injury.

Authors:  B N J Thomson; R W Parks; K K Madhavan; O J Garden
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.